The result was in line with the previous reports that APLN/APLNR gene expression were increased in gastric cancer, liver cancer, cholangiocarcinoma, lung cancer, ovarian cancer, prostate cancer, etc., compared with the equivalent normal tissues or cells [6]. This evidence concerns the gene APLNR and prostate cancer.